Priority dates, work visas, and labor market data
H-1B & Green Card Sponsorship Data
Source: US Dept of Labor. Represents Base Salary only. Excludes RSUs, signing bonuses, and variable compensation. View All Salary RecordsTotal Filings
2021-PresentApproval Rate
Certified CasesMedian Salary
Across All RolesYoY Growth
Filing Volume| Program | Last Filing | Total (2021–Present) |
|---|---|---|
| H-1B | May 28, 2025 | 23 |
| Role | Last Filing | Total (2021–Present) |
|---|---|---|
| Senior Corporate Counsel, Corporate and Business Development | May 28, 2025 | 1 |
| Scientist | Apr 1, 2025 | 1 |
| Director, WW HEOR Hematology - Multiple Myeloma | Jun 27, 2024 | 2 |
| Director, Global Pricing Strategy Cell Therapy | Mar 21, 2024 | 1 |
| Audit & Assurance Senior | Feb 26, 2024 | 1 |
| Role | Count | Median Salary | Min | Max |
|---|---|---|---|---|
| Principal Clinical Biomarker Scientist | 4 | $170,062 | $165,000 | $180,300 |
| Associate Director, Medical Safety Assessment Physician | 2 | $218,709 | $215,000 | $222,417 |
| Director, WW HEOR Hematology - Multiple Myeloma | 2 | $240,000 | $240,000 | $240,000 |
| Director, Worldwide Commercial Cendakimab | 2 | $204,787 | $161,173 | $248,400 |
| Director, Worldwide Deucravacitinib Commercial Marketing | 2 | $210,000 | $210,000 | $210,000 |
| Executive Director, Melanoma/GU | 2 | $220,564 | $205,534 | $235,595 |
| Research Investigator | 2 | $125,000 | $125,000 | $125,000 |
| Audit & Assurance Senior | 1 | $107,520 | $107,520 | $107,520 |
| Automation Engineer | 1 | $92,000 | $92,000 | $92,000 |
| Director, Global Pricing Strategy Cell Therapy | 1 | $231,750 | $231,750 | $231,750 |
| Fiscal Year | Filings | Median Salary | Approval Rate |
|---|---|---|---|
| FY 2021 | 10 | $181,495 | 100.0% |
| FY 2022 | 2 | $171,711 | 100.0% |
| FY 2023 | 5 | $199,336 | 100.0% |
| FY 2024 | 4 | $204,818 | 75.0% |
| FY 2025 | 4 | $219,884 | 100.0% |
| Program | Median Days | Avg Days | P25–P75 | Cases |
|---|---|---|---|---|
| H-1B | 7 | 6 | 7–7 | 23 |